Weekly Digest – October 2024 Weekly Digest – October 2024 14 Oct 2024: ENHERTU approved in China as first HER2 directed therapy for patients with HER2 mutant metastatic non-small cell lung cancer Daiichi Sankyo and AstraZeneca’s ENHERTU has received conditional […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id